Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $28.4 million.

  • Cumberland Pharmaceuticals' Other Operating Expenses fell 5.39% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year decrease of 11.20%. This contributed to the annual value of $28.4 million for FY2024, which is 5869.95% up from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Other Operating Expenses is $28.4 million, which was up 5,869.95% from $475,000 recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Operating Expenses peaked at $30.8 million during FY2022, and registered a low of $475,000 during FY2023.
  • For the 3-year period, Cumberland Pharmaceuticals' Other Operating Expenses averaged around $19.9 million, with its median value being $28.4 million (2024).
  • In the last 5 years, Cumberland Pharmaceuticals' Other Operating Expenses slumped by 98.46% in 2023 and then spiked by 5,869.95% in 2024.
  • Over the past 5 years, Cumberland Pharmaceuticals' Other Operating Expenses (Yearly) stood at $27.9 million in 2020, then increased by 1.24% to $28.2 million in 2021, then rose by 9.39% to $30.8 million in 2022, then plummeted by 98.46% to $475,000 in 2023, then soared by 5,869.95% to $28.4 million in 2024.